| Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma MK Samur, M Fulciniti, A Aktas Samur, AH Bazarbachi, YT Tai, ... Nature communications 12 (1), 868, 2021 | 264 | 2021 |
| Current status of autologous stem cell transplantation for multiple myeloma R Al Hamed, AH Bazarbachi, F Malard, JL Harousseau, M Mohty Blood cancer journal 9 (4), 44, 2019 | 250 | 2019 |
| Relapsed refractory multiple myeloma: a comprehensive overview AH Bazarbachi, R Al Hamed, F Malard, JL Harousseau, M Mohty Leukemia 33 (10), 2343-2357, 2019 | 141 | 2019 |
| Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from … R Al Hamed, AH Bazarbachi, M Mohty Bone marrow transplantation 55 (1), 25-39, 2020 | 119 | 2020 |
| Comprehensive review of AL amyloidosis: some practical recommendations R Al Hamed, AH Bazarbachi, A Bazarbachi, F Malard, JL Harousseau, ... Blood Cancer Journal 11 (5), 97, 2021 | 64 | 2021 |
| Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies R Mohty, R Dulery, AH Bazarbachi, M Savani, RA Hamed, A Bazarbachi, ... Blood Cancer Journal 11 (7), 126, 2021 | 38 | 2021 |
| Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update AH Bazarbachi, R Al Hamed, F Malard, A Bazarbachi, JL Harousseau, ... Blood Cancer Journal 12 (3), 47, 2022 | 36 | 2022 |
| Iron overload and chelation therapy in non-transfusion dependent thalassemia R Bou-Fakhredin, AH Bazarbachi, B Chaya, J Sleiman, MD Cappellini, ... International Journal of Molecular Sciences 18 (12), 2778, 2017 | 32 | 2017 |
| Allogeneic transplant for FLT3-ITD mutated AML: a focus on FLT3 inhibitors before, during, and after transplant AH Bazarbachi, R Al Hamed, F Malard, M Mohty, A Bazarbachi Therapeutic Advances in Hematology 10, 2040620719882666, 2019 | 30 | 2019 |
| Impact of adding antithymocyte globulin to posttransplantation cyclophosphamide in haploidentical stem-cell transplantation J El-Cheikh, R Devillier, R Dulery, R Massoud, F Al Chami, N Ghaoui, ... Clinical Lymphoma Myeloma and Leukemia 20 (9), 617-623, 2020 | 29 | 2020 |
| Personalizing rabbit anti-thymocyte globulin therapy for prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: is there an optimal dose? T Shichijo, S Fuji, A Nagler, A Bazarbachi, M Mohty, BN Savani Bone marrow transplantation 55 (3), 505-522, 2020 | 27 | 2020 |
| Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute … AH Bazarbachi, R Al Hamed, M Labopin, B Afanasyev, RM Hamladji, ... Bone marrow transplantation 55 (3), 595-602, 2020 | 25 | 2020 |
| High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma MK Samur, M Roncador, A Aktas Samur, M Fulciniti, AH Bazarbachi, ... Blood 141 (14), 1724-1736, 2023 | 24 | 2023 |
| Impact of cyclosporine A concentration on acute graft‐vs‐host disease incidence after haploidentical hematopoietic cell transplantation N Stocker, R Dulery, G Battipaglia, E Brissot, C Médiavilla, S Sestili, ... European journal of haematology 103 (1), 10-17, 2019 | 20 | 2019 |
| IgM-MM is predominantly a pre–germinal center disorder and has a distinct genomic and transcriptomic signature from WM AH Bazarbachi, H Avet-Loiseau, R Szalat, AA Samur, Z Hunter, ... Blood, The Journal of the American Society of Hematology 138 (20), 1980-1985, 2021 | 17 | 2021 |
| A phase 2 study of hyper-CVAD plus ofatumumab as frontline therapy in CD20+ acute lymphoblastic leukemia (ALL): Updated results. AH Bazarbachi, M Yilmaz, F Ravandi, DA Thomas, M Khouri, ... Journal of Clinical Oncology 36 (15_suppl), 7041-7041, 2018 | 15 | 2018 |
| Biallelic loss of BCMA triggers resistance to anti-BCMA CAR T cell therapy in multiple myeloma MK Samur, M Fulciniti, A Aktas-Samur, AH Bazarbachi, YT Tai, ... Blood 136, 14, 2020 | 14 | 2020 |
| Current status of autologous stem cell transplantation for multiple myeloma. Blood Cancer J 9: 44 R Al Hamed, AH Bazarbachi, F Malard, JL Harousseau, M Mohty | 14* | 2019 |
| Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from … AH Bazarbachi, R Al Hamed, M Labopin, K Halaburda, H Labussiere, ... Bone marrow transplantation 56 (4), 917-927, 2021 | 13 | 2021 |
| High-dose melphalan significantly increases mutational burden in multiple myeloma cells at relapse: results from a randomized study in multiple myeloma MK Samur, M Roncador, A Aktas-Samur, M Fulciniti, AH Bazarbachi, ... Blood 136, 4-5, 2020 | 13 | 2020 |
Rama Al HamedInternal Medicine Resident, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New在 nychhc.org 的电子邮件经过验证
